Levetiracetam in L-dopa-induced dyskinesia

Clinical Neuropharmacology

Volumn 28, Issue 2, 2005, Pages 102-103

  Meco, G ^a   Fabrizio, E ^a   Epifanio, A ^b   Di Raimondo, G ^b   Vanacore, N ^c   Morgante, L ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; ETIRACETAM; LEVODOPA;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSKINESIA; FEMALE; HUMAN; LETTER; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SOMNOLENCE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTICONVULSANTS; ANTIPARKINSON AGENTS; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PIRACETAM; TREATMENT OUTCOME;

EID: 16344386164     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnf.0000157067.50948.2c     Document Type: Letter

References (5)

1. Cerenghino JJ, Biton V, Abou-Khalil B, et al. Levetiracetam for partial seizures; result of a double blind, randomized clinical trial. Neurology. 2000;55:236-242.
2. Chatterjee A, Louis ED, Frucht S. Levetiracetam in the treatment of paroxysmal kinesigenic choreoathetosis. Mov Disord. 2002;17:614-615.
3. McGavin CL, John V, Musser WS. Levetiracetam as a treatment for tardive dyskinesia: a case report. Neurology. 2003;51:419.
4. Hill MP, Bezard E, McGuire SG, et al. Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset. Mov Disord. 2003;11:1301-1305.
5. Bezard E, Hill MP, Crossman AR, et al. Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque. Eur J Pharmacol. 2004;485:159-164.